Vectura Group Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
397
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$192M
Vectura Group General Information
Description
Provider of drug development services intended to offer treatment of inhaled airway diseases. The company is engaged in inhaled product formulation, drug formulation, drug development, drug manufacturing, and integrated inhaled drug delivery platforms to help patients suffering from airway diseases.
Contact Information
Website
www.vectura.com(Operating Subsidiary)
Corporate Office
- One Prospect West Wiltshire
- Chippenham SN14 6FH
- England, United Kingdom
Corporate Office
- One Prospect West Wiltshire
- Chippenham SN14 6FH
- England, United Kingdom
Vectura Group Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 31-Dec-2024 | $192M | Completed | Generating Revenue | ||
| 9. Secondary Transaction - Private | 19-Sep-2023 | Cancelled | Generating Revenue | |||
| 8. Merger/Acquisition | 15-Sep-2021 | Completed | Generating Revenue | |||
| 7. Buyout/LBO | 26-May-2021 | Cancelled | Generating Revenue | |||
| 6. Merger/Acquisition | 15-Jan-2018 | Cancelled | Generating Revenue | |||
| 5. PIPE | 25-Mar-2014 | Completed | Generating Revenue | |||
| 4. IPO | 02-Jul-2004 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 24-Apr-2001 | Completed | Product Development | |||
| 2. Early Stage VC | 24-Feb-1999 | $2.85M | $2.85M | Completed | Product Development | |
| 1. Seed Round | Completed | Startup |
Vectura Group Comparisons
Industry
Financing
Details
Vectura Group Competitors (1)
One of Vectura Group’s competitors is Aradigm, a Formerly PE-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aradigm | Formerly PE-Backed | Hayward, CA |
Vectura Group Patents
Vectura Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026132215-A1 | Dry powder inhaler | Pending | 19-Dec-2024 | ||
| WO-2026078074-A1 | Dry powder inhaler | Pending | 09-Oct-2024 | ||
| WO-2026078086-A1 | Dry powder inhaler | Pending | 09-Oct-2024 | ||
| WO-2026017276-A1 | Soft mist inhaler | Pending | 17-Jul-2024 | ||
| WO-2025252976-A1 | Dry powder inhaler | Pending | 07-Jun-2024 | A61M15/0008 |
Vectura Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vectura Group Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascenion | Accelerator/Incubator | |||
| Beringea | Venture Capital | Minority | ||
| Court Square | PE/Buyout | Minority | ||
| Excalibur Group Holdings | Corporation | Minority | ||
| Gateway VCT | Venture Capital | Minority |
Vectura Group Investments & Acquisitions (10)
Vectura Group’s most recent deal was a Later Stage VC with EnBiotix for . The deal was made on 29-Dec-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| EnBiotix | 29-Dec-2021 | Later Stage VC | Drug Discovery | ||
| Kinnovata | 01-Jan-2017 | Joint Venture | Drug Discovery | ||
| Skyepharma | 10-Jun-2016 | Merger/Acquisition | BPO/Outsource Services | ||
| Activaero | 13-Mar-2014 | Merger/Acquisition | Drug Discovery | ||
| Ventaleon | 01-Jan-2012 | Early Stage VC | Pharmaceuticals |
Vectura Group ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Vectura Group Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Activaero | Gemunden Am Main, Germany | 1998 | |
| ML Laboratories | Warrington, United Kingdom | 1987 |
Vectura Group FAQs
-
When was Vectura Group founded?
Vectura Group was founded in 1997.
-
Where is Vectura Group headquartered?
Vectura Group is headquartered in Chippenham, United Kingdom.
-
What is the size of Vectura Group?
Vectura Group has 397 total employees.
-
What industry is Vectura Group in?
Vectura Group’s primary industry is BPO/Outsource Services.
-
Is Vectura Group a private or public company?
Vectura Group is a Private company.
-
What is the current valuation of Vectura Group?
The current valuation of Vectura Group is .
-
What is Vectura Group’s current revenue?
The current revenue for Vectura Group is .
-
How much funding has Vectura Group raised over time?
Vectura Group has raised $105M.
-
Who are Vectura Group’s investors?
Ascenion, Beringea, Court Square, Excalibur Group Holdings, and Gateway VCT are 5 of 12 investors who have invested in Vectura Group.
-
Who are Vectura Group’s competitors?
Aradigm is a competitor of Vectura Group.
-
When was Vectura Group acquired?
Vectura Group was acquired on 31-Dec-2024.
-
Who acquired Vectura Group?
Vectura Group was acquired by Phillips Medisize.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
